Cargando…
Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
Since patients with medullary thyroid cancer (MTC) often have metastatic disease at the time of diagnosis, the development of efficient systemic treatment options for MTC is important. Vandetanib and cabozantinib are two tyrosine kinase inhibitors (TKIs) that were recently approved by FDA and EMA fo...
Autores principales: | Sandblom, Viktor, Spetz, Johan, Shubbar, Emman, Montelius, Mikael, Ståhl, Ingun, Swanpalmer, John, Nilsson, Ola, Forssell-Aronsson, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252631/ https://www.ncbi.nlm.nih.gov/pubmed/32459817 http://dx.doi.org/10.1371/journal.pone.0233720 |
Ejemplares similares
-
Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer
por: Sandblom, Viktor, et al.
Publicado: (2019) -
(177)Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition
por: Hofving, Tobias, et al.
Publicado: (2019) -
Multiparametric MR for non‐invasive evaluation of tumour tissue histological characteristics after radionuclide therapy
por: Montelius, Mikael, et al.
Publicado: (2019) -
Hyperfractionated Treatment with (177)Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor Model
por: Elvborn, Mikael, et al.
Publicado: (2022) -
Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
por: Larsson, Malin, et al.
Publicado: (2020)